Dendritic cells (DC) become fully functional upon maturation by various stimuli. We tested whether an immunostimulatory effect of clinically used immunomodulators (Luivac, Biostim, Ribomunyl, Imudon, Bronchovaxom) is caused by direct DC activation. We found that Luivac, Biostim and Ribomunyl have a very high DC stimulatory potential in vitro. The level of DC activation was comparable or higher than DC maturation induced by standard maturation stimuli, Poly (I:C) or lipopolysaccharide. Treated DC had activated phenotype, reduced phagocytic activity and they induced the proliferation of allogeneic T lymphocytes. These results are important for understanding the physiology of action of these widely prescribed agents. Administration of bacterial immunomodulators should be considered with care to avoid the potential risk of inducing an autoimmune disease. They could also be used as well-defined maturating agents in the protocols used for the ex vivo production of DC-based vaccines for clinical trials.

Institute of Immunology 2nd Medical Faculty Charles University 5 Uvalu 84 150 06 Prague 5 Czech Republic

Citace poskytuje Crossref.org

Viral infections and wheezing-asthma inception in childhood: is there a role for immunomodulation by oral bacterial lysates?

Bordetella adenylate cyclase toxin differentially modulates toll-like receptor-stimulated activation, migration and T cell stimulatory capacity of dendritic cells

Poly I: C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials

Comparison of the Effect of Ribosomal Immunotherapy on Plasma Levels of Total IgE and Cytokines IL-4, IL-5, IL-12 and IFNgamma in Adult Atopic and Non-Atopic Patients during the Pollen Season